Global Health Battles: Obesity Drug Expansion, Vaccine Alliances, and Policy Shifts
Current health news highlights include Eli Lilly's global obesity drug expansion, Northeast US states forming a vaccine coalition, and controversies over vaccine policy. Additionally, WHO addresses barriers to health reforms, and Texas enacts strict measures against mail-order abortion pills amidst various drug-related mergers and acquisitions.

Eli Lilly aims to establish global leadership in obesity drugs, utilizing consumer-focused strategies and collaborations with digital platforms, as articulated by the company's international president, Patrik Jonsson. This follows their successful U.S. market approach, extending partnerships to markets like Australia and China.
In response to changing federal policies on vaccines, seven northeastern U.S. states are forming a coalition to guide their own recommendations. This move mirrors initiatives on the West Coast and highlights ongoing tensions with federal directives under the Trump administration.
The World Health Organization criticizes the influence of tobacco, alcohol, and processed food companies on health policy. WHO underscores the need for robust policy measures against such industries, emphasizing their contribution to non-communicable diseases during a significant UN gathering.
(With inputs from agencies.)
ALSO READ
Ebola in DRC: WHO's Swift Response Amidst Rising Cases
Deeply feel pain of investors who lost money because of 'fraudulent and motivated' Hindenburg report, says Gautam Adani.
CEC 'protecting' people who have 'destroyed' Indian democracy: Rahul Gandhi at press conference.
As a patriotic Indian who loves Constitution, it is my duty to bring truth to protect democracy: Rahul Gandhi on vote theft allegations.
WHO Restores Sunscreen to Essential Medicines List, Boosting Rights of Albinos